GT Biopharma (NASDAQ:GTBP) reported quarterly losses of $(0.22) per share. This is a 29.41 percent decrease over losses of $(0.17) per share from the same period last year.
Erie Indemnity Approves Management Fee Rate At 25%, Effective Jan. 1.; Dividend Increase From $1.19 To $1.275 On Each Class A Share, Declares Regular Dividends
At its regular meeting held Dec. 5, 2023, the Board of Directors of Erie Indemnity Company (NASDAQ:ERIE) set the management fee rate charged to Erie Insurance Exchange, approved an increase in shareholder dividends and
